Aprea Therapeutics Inc APRE

‎$‎0.71540.01(1.65%)(1D)

• Delayed prices by NASDAQ • in USD

Invest in Aprea Therapeutics Inc
Today

Create an eToro account to buy APRE stock on a secure, user-friendly, multi-asset trading platform.

Aprea Therapeutics Inc APRE

Buy APRE

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

EIFF.PA

Societe de la Tour Eiffel SA

Eastman Kodak Company

Alerion Clean Power S.p.A

‎€‎21.75

+6.36%

SBAC

SBA Communications Corporation

MAX

*Past performance is not an indication of future results

Jump to:

About APRE >
How to Buy? >
Top Guides >

The Aprea Therapeutics Inc share price is stable this week.

The Aprea Therapeutics Inc price today is ‎$‎0.7154, a ‎1.65‎% change in the last 24 hours and ‎0‎% in the past week. Aprea Therapeutics Inc price changed by ‎0‎% in the past year.

APRE Key Metrics

Market Cap

Day’s Range

‎$‎0.6433 - ‎$‎0.7153

52W Range

‎$‎0.548 - ‎$‎1.48

Average Volume (3M)

Price-Earnings Ratio

Revenue

Dividend (Yield)

Prev Close

‎$‎0.7154

EPS

Beta

How can I buy Aprea Therapeutics Inc stocks?

To purchase Aprea Therapeutics Inc:

Create an eToro account:

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.

Search and purchase:

Search the Aprea Therapeutics Inc (APRE) page and place an order to buy Aprea Therapeutics Inc.

Buy APRE

Looking for more information? Check out our guide on Academy.

What Is Aprea Therapeutics Inc?

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company located in the United States dedicated to developing innovative anti-cancer therapies. Serving the US and France, it focuses on addressing specific tumour suppressor pathways that are often dysfunctional in various cancers. The company's primary aim is to create effective treatments for patients.

Operating within the biotechnology sector, Aprea Therapeutics Inc specialises in reactivating mutant tumour suppressor proteins, particularly targeting the p53 pathway. The research aims to restore the body's natural defence mechanisms to potentially inhibit tumour growth and improve patient outcomes.

Monitor the APRE share price by adding it to your eToro watchlist.

This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.

CEO

Oren Gilad, PhD

Employees

Founded

2002

Doylestown, Pennsylvania, US

Med Tech

NASDAQ

Get Started

Top Guides

Our top picks for the most relevant guides from the eToro Academy

Top Dividend Stocks for 2026

Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.

Stock Trading And Investing For Beginners

Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.

AI Stocks Poised for Growth in 2026

Gear up for 2026 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.

Go to the Academy >

Invest in Aprea Therapeutics Inc
Today

Create an eToro account to buy APRE stock on a secure, user-friendly, multi-asset trading platform.

Get Started

FAQ

What is the current price of Aprea Therapeutics Inc stock?

The current price of APRE is ‎$‎0.7154.

What are analysts’ forecasts for Aprea Therapeutics Inc?

Analysts offer forecasts for Aprea Therapeutics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.

What is the market cap of Aprea Therapeutics Inc?

The market capitalisation of Aprea Therapeutics Inc is (The data is unavailable right now)

Daily Movers

Explore the biggest stocks movers on the market.